Nephrotic syndrome is the most common glomerular disease in childhood, with a prevalence of 16 patients per 100,000 children. Approximately 80% will have steroid-sensitive nephrotic syndrome (SSNS); 50% of those will be frequently relapsing or steroid dependent, with some requiring additional medications to reduce steroid toxicity. 1 Those with steroid-resistant nephrotic syndrome (SRNS) often trial several side effect-laden treatments, experience reduced renal function, and may develop ESKD. 2 The promise of precision medicine is to better predict individual patient outcomes from this broad range of possibilities and help determine the optimal treatment course at disease onset. This requires an improved understanding of the pathophysiology of nephrotic syndrome and its genetic underpinnings. Gene identification has already revolutionized our understanding of SRNS, with over 50 causative genes identified. 1 For those with SRNS under the age of 25 years old, approximately 30% will have a known single-gene cause and are unlikely to respond to steroid treatment, allowing them to more quickly move to steroid-sparing agents. 3 Despite evidence of heritability, including familial clustering and ethnic preponderances, genetics has not yielded similar insights for SSNS. Attempts to find monogenic causes of SSNS via candidate gene, family-based, or whole-exome mapping approaches have generally identified genetic loci with a mixed SSNS/SRNS phenotype or that are part of a systemic syndrome. This suggests that the genetic contribution to isolated SSNS may follow a model of polygenic inheritance, with additive contributions of many individual disease alleles with